Prognostic and predictive value of MET deregulation in non-small cell lung cancer
about
Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker.Targeting MET in Lung Cancer: Will Expectations Finally Be MET?Biology and clinical significance of circulating tumor cell subpopulations in lung cancerNon-small cell lung cancer treatment (r)evolution: ten years of advances and more to come.Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinib.Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells
P2860
Q37346559-AA63B732-0FAC-4F88-A327-81136F36DBEDQ37702041-7E682357-1785-4F6F-8322-6D4FD42B7D2BQ38994327-BDB39C7B-47BC-4433-9667-B28AC3D206D0Q41605032-6E15B948-D105-4190-8FDF-FB67D45BBBFCQ47139758-81800B65-65FE-4636-ABB2-4B30562CAADDQ54162899-A1A048BA-FE2F-499C-9664-07779269BD46Q58762813-AE175828-CC77-4150-B453-4270CB387073
P2860
Prognostic and predictive value of MET deregulation in non-small cell lung cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic and predictive value of MET deregulation in non-small cell lung cancer
@en
type
label
Prognostic and predictive value of MET deregulation in non-small cell lung cancer
@en
prefLabel
Prognostic and predictive value of MET deregulation in non-small cell lung cancer
@en
P2093
P2860
P1476
Prognostic and predictive value of MET deregulation in non-small cell lung cancer
@en
P2093
Giovanna Finocchiaro
Letizia Gianoncelli
Luca Toschi
Marina Baretti
P2860
P356
10.3978/J.ISSN.2305-5839.2015.03.43
P577
2015-04-01T00:00:00Z